- Home
- ATXG vs SNGX Comparison
ATXG vs SNGX Comparison
Compare ATXG & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- SNGX
- Stock Information
- Founded
- ATXG 2014
- SNGX 1987
- Country
- ATXG China
- SNGX United States
- Employees
- ATXG N/A
- SNGX N/A
- Industry
- ATXG Professional Services
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- SNGX Health Care
- Exchange
- ATXG Nasdaq
- SNGX Nasdaq
- Market Cap
- ATXG 3.8M
- SNGX 6.5M
- IPO Year
- ATXG N/A
- SNGX 1987
- Fundamental
- Price
- ATXG $0.75
- SNGX $1.97
- Analyst Decision
- ATXG
- SNGX
- Analyst Count
- ATXG 0
- SNGX 0
- Target Price
- ATXG N/A
- SNGX N/A
- AVG Volume (30 Days)
- ATXG 18.5K
- SNGX 198.4K
- Earning Date
- ATXG 02-14-2025
- SNGX 05-20-2025
- Dividend Yield
- ATXG N/A
- SNGX N/A
- EPS Growth
- ATXG N/A
- SNGX N/A
- EPS
- ATXG N/A
- SNGX N/A
- Revenue
- ATXG $4,549,310.00
- SNGX $119,371.00
- Revenue This Year
- ATXG N/A
- SNGX N/A
- Revenue Next Year
- ATXG N/A
- SNGX N/A
- P/E Ratio
- ATXG N/A
- SNGX N/A
- Revenue Growth
- ATXG N/A
- SNGX N/A
- 52 Week Low
- ATXG $0.49
- SNGX $1.68
- 52 Week High
- ATXG $1.18
- SNGX $14.83
- Technical
- Relative Strength Index (RSI)
- ATXG 50.89
- SNGX 44.70
- Support Level
- ATXG $0.69
- SNGX $1.85
- Resistance Level
- ATXG $0.89
- SNGX $2.00
- Average True Range (ATR)
- ATXG 0.10
- SNGX 0.12
- MACD
- ATXG 0.01
- SNGX -0.00
- Stochastic Oscillator
- ATXG 33.94
- SNGX 34.15
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).